|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/11 | |
| A61K 31/7088 |
| (11) | Number of the document | 2340308 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10737580.0 |
| Date of filing the European patent application | 2010-07-30 | |
| (97) | Date of publication of the European application | 2011-07-06 |
| (45) | Date of publication and mention of the grant of the patent | 2014-12-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2010/061152 |
| Date | 2010-07-30 |
| (87) | Number | WO 2011/012713 |
| Date | 2011-02-03 |
| (30) | Number | Date | Country code |
| 09166893 | 2009-07-30 | EP |
| (72) |
SCHLINGENSIEPEN, Karl-Hermann, DE
JASCHINSKI, Frank, DE
ROTHAMMER, Tanja, DE
SCHNEIDER, Anneliese, DE
|
| (73) |
ISARNA Therapeutics GmbH,
Leopoldstrasse 254-256, 80807 München,
DE
|
| (54) | Combination of dacarbazine and an inhibitor of the TGF-beta system |
| Combination of dacarbazine and an inhibitor of the TGF-beta system |